The biology and pathology of “young age” prostate cancer

A recent article in the Journal of Clinical Pathology reviews available data about the epidemiology, biology, and clinical pathology of “young age” prostate cancer, which the authors define as clinically significant cancer in men under 55 years of age. … READ MORE …

Prediction of the “real” risk of death from prostate cancer

A while ago now we first discussed research being done by Eric Feuer and others on what was initially being called the Cancer Survival Query System or CSQS. … READ MORE …

Ageism in prostate cancer treatment

We’ve all heard the age-related treatment recommendations of doctors. … READ MORE …

Testosterone supplements, rats, and risk for prostate cancer in healthy, aging men

The “New” Prostate Cancer InfoLink has long argued that the use of testosterone supplements by otherwise healthy men as they age (as a way to try to maintain the vigor and libido of their youth) comes with risks, and that one of those risks is the risk for a diagnosis of prostate cancer. … READ MORE …

Over-use of PSA testing in men > 65 with short life expectancies?

Why is it that we seem to be so focused on testing for risk of prostate cancer in older men with life expectancies of < 10 years, i.e., men who are almost certainly at very low risk for clinically significant disease? … READ MORE …

Prostate cancer in younger men: an important new review

An article in this month’s issue of Nature Reviews: Urology has looked closely at a question of significant relevance to an important subset of our regular readers — Is prostate cancer in some way “different” in younger men? … READ MORE …

Risk evaluation among men initially diagnosed with T1cN0M0 disease

A recent paper in Frontiers in Oncology offers us new information about the risk profiles of men initially diagnosed with clinical stage T1c disease in the USA in relatively recent years. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,300 other followers